Table 1.
Source | Country | # of patients | Years of enrollment | Study type | Age, years | HCV % Known | HCV % Positive | Black race, % | Male, % |
---|---|---|---|---|---|---|---|---|---|
Ahuja et al 1999 | United States | 557 | 1998 | CS | 37 | 100 | 23.3 | 50.0 | 79.7 |
Bagnis et al, 2006 | France | 1219 | 2001 | CS | 42 | 78.8 | 14.2 | NA | 76.1 |
Becker et al, 2004 | United States | 6022 | 1997–2003 | PC | 43 | NA | 11.4 | 14.9 | 90.9 |
Brodie et al, 1998 | United States | 79 | 1995–1997 | RC | NA | 93.7 | 34.2 | NA | 60.8 |
Dieleman et al, 2003 | Netherlands | 184 | 1998–2000 | PC | 41 | 41.8 | 6.0 | NA | 81.3 |
Duval et al, 2004 | France | 1155 | 1997–1999 | PC | 36 | 90.4 | 23.7 | NA | 77 |
Franceschini et al, 2006 | United States | 705 | 2000–2002 | PC | 40 | 100 | 22.7 | 61.0 | 68.7 |
Gallant et al, 2005 | United States | 658 | 2001–2003 | RC | 38 | NA | 36.9 | 73.7 | 71.6 |
Gardner et al, 2003a | United States | 885 | 1993–2000 | PC | NA | 98.8 | 56.3 | 60.8 | 0 |
Gardner et al, 2003b | United States | 885 | 1993–2000 | PC | NA | 98.8 | 56.3 | 60.8 | 0 |
Gupta et al, 2004 | United States | 487 | 1990–1998 | RC | 34 | 52.4 | 13.6 | 52.4 | 81.5 |
Jung et al, 2004 | Germany | 214 | 2001–2002 | PC | 42 | 100 | 3.3 | 2.3 | 89.7 |
Krawczyk et al, 2004 | United States | 394 | 1992–2002 | CC | 43 | 100 | 21.1 | 48.0 | 82.2 |
Kulkarni et al, 2003 | United States | 828 | 1993–1998 | RC | 31 | 62 | 58.1 | 23.8 | 100 |
Lopes et al, 2007 | Portugal | 97 | 2002–2006 | RC | 43 | 100 | 20.6 | 28.9 | 79.4 |
Lucas et al, 2004 | United States | 3976 | 1989–2001 | PC | 37 | 74.5 | 52 | 77.0 | 70 |
Malavaud et al, 2001 | France | 112 | 1998 | CC | 40 | 100 | 11.6 | NA | 73.2 |
Meraviglia et al, 2002 | Italy | 555 | 1997 | PC | 38 | 100 | 46.1 | 1.4 | 77.1 |
Mocroft et al, 2007 | Europe | 4474 | 2004–2005 | CS | 43 | 84.9 | 20.6 | 14.5* | 76.1 |
Padilla et al, 2005 | Spain | 316 | 2001–2003 | CC | 40 | 54.7 | 32.0 | 1.3 | 76.0 |
Reisler et al, 2003 | United States | 2947 | 1996–2001 | PC | 39 | 55.2 | 9.9 | 44.8 | 83.0 |
Shahinian et al, 2000 | United States | 389 | 1992–1997 | CS | 40 | 47.8 | 20.6 | 54.0 | 93.1 |
Szczech et al, 2002 | United States | 2057 | 1994–1999 | PC | 37 | 100 | 41.5 | 55.5 | 0 |
Szczech et al, 2004 | United States | 89 | 1995–2001 | RC | 42¶ | 92.1 | 47.2 | 88.8 | 82.0 |
Szczech et al, 2007 | United States | 760 | 1999 | CS | 44 | 100 | 23.2 | 44.0 | 73.7 |
Tedaldi et al, 2003 | United States | 823 | 1996–2001 | PC | 37¶ | 100 | 32.4 | 64.3* | NA |
Winston et al, 2006 | Australia | 948 | 2005 | PC | 45¶ | NA | 7.1 | NA | 95.8 |
Abbreviations CS, Cross-sectional, PC, Prospective cohort, RC, Retrospective cohort, CC, case control, HCV, Hepatits C virus status, NA, Not available
weighted average
Non-white race; all percentages represent the proportion of the total study population